A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
Pharmacokinetic Evaluation of the CYP3A4 and CYP2D6 Drug-Drug Interaction and CYP3A4 Induction Potential of Omecamtiv Mecarbil: Two Open-Label Studies in Healthy Subjects
American College of Clinical Pharmacology
Trivedi A, Malik FI, Jafarinasabian P, Zhang H, Flach S, Abbasi S, Dutta S, Lee E
May 12, 2021
Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil
Clinical Pharmacokinetics
Trivedi A, Oberoi RK, Jafarinasabian P, Zhang H, Flach S, Abbasi S, Dutta S, Lee E
March 26, 2021
Discovery of CK-274: A novel, small molecule, cardiac myosin inhibitor for the treatment of hypertrophic cardiomyopathies (HCM)
Presentation, American Chemical Society (ACS) Spring Meeting 2021
Virtual
April 9, 2021
Impact of Patient Characteristics on Effect Size in FORTITUDE-ALS
Poster, 31st International Symposium on ALS/MND
Virtual
December 11, 2020
People Living with ALS and Their Caregivers’ Input into Drug Development in Europe
Poster, 31st International Symposium on ALS/MND
Virtual
December 11, 2020